Adalimumab concentration-based tapering strategy: as good as the recommended dosage

por Mulleman, Denis, Balsa, Alejandro
Publicado 2018

Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients

por Novella-Navarro, Marta, Balsa, Alejandro
Publicado 2022

Risk Factors for Developing Rheumatoid Arthritis in Patients With Undifferentiated Arthritis and Inflammatory Arthralgia

por Novella-Navarro, Marta, Plasencia-Rodríguez, Chamaida, Nuño, Laura, Balsa, Alejandro
Publicado 2021

Comment on: Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilization

por Benavent, Diego, Fernández-Luque, Luis, Navarro-Compán, Victoria, Balsa, Alejandro, Plasencia, Chamaida
Publicado 2021

Validity of the EULAR recommendations on the use of ultrasound in the diagnosis of giant cell arteritis

por Fernández-Fernández, Elisa, Monjo, Irene, Peiteado, Diana, Balsa, Alejandro, De Miguel, Eugenio
Publicado 2022

Treat-To-Target and Treat-To-Budget in Rheumatoid Arthritis: Measuring the Value of Individual Therapeutic Interventions

por Sacristán, José A., Díaz, Silvia, de la Torre, Inmaculada, Inciarte-Mundo, José, Balsa, Alejandro
Publicado 2019

The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review

por Taylor, Peter C., Atzeni, Fabiola, Balsa, Alejandro, Gossec, Laure, Müller-Ladner, Ulf, Pope, Janet
Publicado 2021

Healthcare-related impact of gout in hospitalized patients in Spain

por Benavent, Diego, Peiteado, Diana, Martinez-Huedo, María Ángeles, Hernandez-Hurtado, María, Balsa, Alejandro, de Miguel, Eugenio
Publicado 2021

Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature review

por Navarro-Compán, Victoria, Plasencia-Rodríguez, Chamaida, de Miguel, Eugenio, Diaz del Campo, Petra, Balsa, Alejandro, Gratacós, Jordi
Publicado 2017

CNstream: A method for the identification and genotyping of copy number polymorphisms using Illumina microarrays

por Alonso, Arnald, Julià, Antonio, Tortosa, Raül, Canaleta, Cristina, Cañete, Juan D, Ballina, Javier, Balsa, Alejandro, Tornero, Jesús, Marsal, Sara
Publicado 2010

Axial spondyloarthritis and axial psoriatic arthritis: similar or different disease spectrum?

por Benavent, Diego, Plasencia-Rodríguez, Chamaida, Franco-Gómez, Karen, Nieto, Romina, Monjo-Henry, Irene, Peiteado, Diana, Balsa, Alejandro, Navarro-Compán, Victoria
Publicado 2020

Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis

por Hernández-Breijo, Borja, Brenis, Claudia M., Plasencia-Rodríguez, Chamaida, Martínez-Feito, Ana, Novella-Navarro, Marta, Pascual-Salcedo, Dora, Balsa, Alejandro
Publicado 2021

Baricitinib and the Risk of Incident Interstitial Lung Disease: A Descriptive Clinical Case Report from Clinical Trials

por Salvarani, Carlo, Sebastiani, Marco, Dieude, Philippe, Garcia, Miriam, Deberdt, Walter, Rogai, Veronica, de la Torre, Inmaculada, Inciarte-Mundo, José, Balsa, Alejandro
Publicado 2021

Immunogenicity of Biologics in Chronic Inflammatory Diseases: A Systematic Review

por Strand, Vibeke, Balsa, Alejandro, Al-Saleh, Jamal, Barile-Fabris, Leonor, Horiuchi, Takahiko, Takeuchi, Tsutomu, Lula, Sadiq, Hawes, Charles, Kola, Blerina, Marshall, Lisa
Publicado 2017

Coping with rheumatic stressors (CORS) questionnaire: Spanish translation and cross-cultural adaptation

por Benavent, Diego, Jochems, Andrea, Pascual-Salcedo, Dora, Jochems, Gijs, Plasencia-Rodríguez, Chamaida, Ramiro, Sofia, van Lankveld, Wim, Balsa, Alejandro, Navarro-Compán, Victoria
Publicado 2023

Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents

por Reinisch, Walter, Jahnsen, Jørgen, Schreiber, Stefan, Danese, Silvio, Panés, Julián, Balsa, Alejandro, Park, Won, Kim, JiSoo, Lee, Jee Un, Yoo, Dae Hyun
Publicado 2017

Comparison of long-term efficacy between biological agents following tumor necrosis factor inhibitor failure in patients with rheumatoid arthritis: a prospective cohort study

por Bogas, Patricia, Plasencia-Rodriguez, Chamaida, Navarro-Compán, Victoria, Tornero, Carolina, Novella-Navarro, Marta, Nuño, Laura, Martínez-Feito, Ana, Hernández-Breijo, Borja, Balsa, Alejandro
Publicado 2021

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients

por Regueiro, Cristina, Nuño, Laura, Ortiz, Ana M., Peiteado, Diana, Villalba, Alejandro, Pascual-Salcedo, Dora, Martínez-Feito, Ana, González-Alvaro, Isidoro, Balsa, Alejandro, González, Antonio
Publicado 2017

Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib

por Combe, Bernard, Balsa, Alejandro, Sarzi-Puttini, Piercarlo, Tony, Hans-Peter, de la Torre, Inmaculada, Rogai, Veronica, Durand, Frederick, Witt, Sarah, Zhong, Jinglin, Dougados, Maxime
Publicado 2019

Improved RA classification among early arthritis patients with the concordant presence of three RA autoantibodies: analysis in two early arthritis clinics

por Regueiro, Cristina, Rodríguez-Martínez, Lorena, Nuño, Laura, Ortiz, Ana M., Villalba, Alejandro, Pascual-Salcedo, Dora, Martínez-Feito, Ana, González-Alvaro, Isidoro, Balsa, Alejandro, Gonzalez, Antonio
Publicado 2019